Company Overview of Suneva Medical, Inc.
Suneva Medical, Inc. is an aesthetics company that develops, manufactures, and commercializes products for general dermatology and aesthetic markets. It offers Bellafill, a dermal filler for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age group of 21 years; Regenica, a skin care system that enhances skin’s natural capacity to renew, repair, and prevent the signs of aging; and ReFissa, a prescription medicine that reduces fine facial wrinkles, as well as fades irregular pigmentation caused due to sun damage. It serves clients in the United States, Canada, Hong Kong, South Korea, and Singapore. Suneva Medi...
5870 Pacific Center Boulevard
San Diego, CA 92121
Founded in 2008
Key Executives for Suneva Medical, Inc.
Chief Executive Officer, President and Director
Vice President of Corporate Development
Vice President of Sales-East
Compensation as of Fiscal Year 2016.
Suneva Medical, Inc. Key Developments
Pat Altavilla Joins Suneva Medical, Inc. as Vice President of Marketing
Oct 10 16
Suneva Medical, Inc. announced the appointment of Pat Altavilla as vice president of marketing. With more than 30 years of experience in the aesthetics and medical fields, Altavilla will oversee all marketing aspects for the company, further fortifying the brand's strong leadership position. Most recently, Altavilla worked for medical technology company ZELTIQ® Aesthetics Inc. where she served in numerous leadership roles including vice president of global physician and practice marketing and vice president, global strategic partnerships and practice development. With ZELTIQ, Altavilla was instrumental in developing the brand's global marketing organization as well as growing physician loyalty, enhancing practice development, launching innovative products, and increasing the company's presence.
Suneva Medical, Inc. Announces Management Changes
Aug 4 16
Suneva Medical, Inc. announced the promotion of Preston Romm to president and chief executive officer, effective immediately. Romm has more than 30 years of experience, recently joined the company as its chief operating officer and has been promoted to president and CEO to further accelerate the company's vision to become a leader in the cash-pay aesthetics market. Nicholas L. Teti, Jr., former chairman and chief executive officer at Suneva Medical has resigned both posts to pursue other interests after championing many successful milestones for the organization over the last six years. In addition to this executive change, the company is further fortifying its leadership with the additions of several new board members. First, Martin P. Sutter, co-founder and managing director at Essex Woodlands will join the board, bringing more than 30 years of management experience in operations, marketing, finance and venture capital. Additionally, Dennis Condon, CEO and president of Nuvesse Skin Therapies will be added to the board. Condon brings more than 30 years of experience in key executive roles in the medical and plastic surgery markets including executive office positions at Merz Aesthetics, BioForm Medical, and Mentor Aesthetics. Preston Romm will also join the company's board and Todd Davis will assume the role of chairman.
Suneva Medical, Inc. Announces 90-Day Results from Regenica® Rejuvenating Dual Serum Clinical Study
Jun 22 16
Suneva Medical, Inc. announced the results of its 90-day clinical study that evaluated Regenica® Rejuvenating Dual Serum. In the study, statistically significant improvements were reported as early as 14 days, with continued improvement seen at 90 days in parameters that included the reduction in the appearance of fine lines, an increase in brightness, skin radiance and improved appearance of skin firmness and blotchiness. The study showed 95% overall patient satisfaction and 87% of patients would recommend the serum to a friend. Regenica® Rejuvenating Dual Serum is the offering within the Regenica® skin care line. Backed by sound science and clinical data, the new serum represents a revolutionary breakthrough in skin care and was specifically developed to improve the appearance of skin tone, texture and brightness, as well as reduce the appearance of fine lines and wrinkles. The powerful, dual chamber serum is created using the most advanced growth factor technology that combines a 95% concentration of MRCx a unique, proprietary blend of growth factors, cytokines and proteins--and anti-aging ingredients including advanced copper peptides, amino acids, antioxidants and plant-based extracts. The 90-day clinical study evaluated 40 women who were asked to use Regenica® Rejuvenating Dual Serum on their entire face, twice daily. Patients reported a reduction in fine lines as early as 14 days, with continued improvement seen through the duration of the study. A reduction in the appearance of coarse wrinkles and blotchiness was also reported. The study showed an increase in brightness and skin radiance, and improved appearance of skin firmness and skin elasticity. Patients reported an improvement in skin health and skin rejuvenation and 95% were satisfied with Regenica® Rejuvenating Dual Serum. When asked about the product's color, 100% of patients were satisfied; over 95% were satisfied with the texture and smell. The primary efficacy endpoint was met for the investigator-assessed rating for overall facial skin appearance.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 6, 2016